Food And Drug Administration-Enzyme Replacement Therapy-Rare Genetic Disorder-Gaucher Disease

Elelyso Approved for Gaucher Disease

TUESDAY, May 1 (Healthday News) -- Elelyso (taliglucerase alfa) has been approved by the U.S. Food And Drug Administration as a long-term enzyme replacement therapy for people with a rare genetic disorder called type 1 Gaucher disease. read more..

source:http://yhoo.it/IpNcN7